Depreciation of Arcutis Biotherapeutics, Inc. from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Arcutis Biotherapeutics, Inc. annual and quarterly Depreciation in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Arcutis Biotherapeutics, Inc. Depreciation for the quarter ending 31 Mar 2025 was $153,000, a 10% decline year-over-year.
  • Arcutis Biotherapeutics, Inc. annual Depreciation for 2025 was $700,000, a 17% increase from 2024.
  • Arcutis Biotherapeutics, Inc. annual Depreciation for 2024 was $600,000, a 25% decline from 2023.
  • Arcutis Biotherapeutics, Inc. annual Depreciation for 2023 was $800,000, a 29% increase from 2022.
Source SEC data
View on sec.gov
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)

Arcutis Biotherapeutics, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $700,000 +$100,000 +17% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $600,000 -$200,000 -25% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $800,000 +$178,000 +29% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $622,000 +$168,000 +37% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
2021 $454,000 +$332,000 +272% 01 Jan 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
2020 $122,000 +$54,000 +79% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $68,000 +$68,000 01 Jan 2019 31 Dec 2019 10-K 22 Feb 2022 2021 FY
2018 $0 01 Jan 2018 31 Dec 2018 10-K 16 Feb 2021 2020 FY

Arcutis Biotherapeutics, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $153,000 -$17,000 -10% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q1 2024 $795,000 $170,000 -$5,000 -2.9% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025 2025 Q1
Q4 2023 $800,000 $227,000 +$67,000 +42% 01 Oct 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
Q3 2023 $733,000 $200,000 +$43,000 +27% 01 Jul 2023 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $690,000 $198,000 +$43,000 +28% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $647,000 $175,000 +$25,000 +17% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 $622,000 $160,000 +$24,000 +18% 01 Oct 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
Q3 2022 $598,000 $157,000 +$41,000 +35% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 $557,000 $155,000 +$51,000 +49% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $506,000 $150,000 +$52,000 +53% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $454,000 $136,000 +$101,000 +289% 01 Oct 2021 31 Dec 2021 10-K 27 Feb 2024 2023 FY
Q3 2021 $353,000 $116,000 +$86,000 +287% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022 2022 Q3
Q2 2021 $267,000 $104,000 +$74,000 +247% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $193,000 $98,000 +$71,000 +263% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q4 2020 $122,000 $35,000 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
Q3 2020 $30,000 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $30,000 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $27,000 +$22,000 +440% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $5,000 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.